Page last updated: 2024-09-05

bn 80927 and topotecan

bn 80927 has been researched along with topotecan in 1 studies

Compound Research Comparison

Studies
(bn 80927)
Trials
(bn 80927)
Recent Studies (post-2010)
(bn 80927)
Studies
(topotecan)
Trials
(topotecan)
Recent Studies (post-2010) (topotecan)
6112,392626792

Protein Interaction Comparison

ProteinTaxonomybn 80927 (IC50)topotecan (IC50)
Cytochrome P450 3A4Homo sapiens (human)1.5211
DNA topoisomerase 1Homo sapiens (human)0.8525
DNA topoisomerase 2-alphaHomo sapiens (human)0.605
DNA topoisomerase 2-betaHomo sapiens (human)0.605
Hypoxia-inducible factor 1-alphaHomo sapiens (human)0.06
Multidrug and toxin extrusion protein 2Homo sapiens (human)8.6
Multidrug and toxin extrusion protein 1Homo sapiens (human)1.3
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, S; Zhang, WN1

Reviews

1 review(s) available for bn 80927 and topotecan

ArticleYear
[Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2004, Volume: 39, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; DNA Damage; Humans; Irinotecan; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured

2004